GenMark Diagnostics to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today
announced that President and Chief Executive Officer, Hany Massarany, will present at the Canaccord Genuity Medical Technologies
& Diagnostics Forum in New York, NY.
Mr. Massarany will participate in an analyst-led fireside chat on Thursday, November 9, at 3:00 PM Eastern Time. Interested
parties may access a live and archived webcast of the event at ir.genmarkdx.com.
About GenMark Diagnostics
GenMark Diagnostics (NASDAQ:GNMK) is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient
care, improve key quality metrics, and reduce the total cost-of-care. Utilizing GenMark's proprietary eSensor® detection
technology, GenMark's eSensor XT-8® and ePlex® systems are designed to support a broad range of molecular diagnostic tests with
compact, easy-to-use workstations and self-contained, disposable test cartridges. GenMark’s ePlex: The True Sample-to-Answer
Solution™ is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs,
including respiratory, bloodstream, and gastrointestinal infections. For more information, visit www.genmarkdx.com.
Investor Relations Contact
GenMark Diagnostics, Inc.
Lynn Pieper Lewis or Leigh Salvo
(415) 937-5404
investors@genmarkdx.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20171107006919/en/